mRNA transcript diversity creates new opportunities for pharmacological intervention.
about
Alternative splicing for diseases, cancers, drugs, and databasesDynorphin--still an extraordinarily potent opioid peptideRNA editing and drug discovery for cancer therapyRNA-seq characterization of spinal cord injury transcriptome in acute/subacute phases: a resource for understanding the pathology at the systems levelCosplicing network analysis of mammalian brain RNA-Seq data utilizing WGCNA and Mantel correlationsGenome annotation for clinical genomic diagnostics: strengths and weaknessesPharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trialsAltered gamma-aminobutyric acid type B receptor subunit 1 splicing in alcoholics.Genomic structure and expression of the human serotonin 2A receptor gene (HTR2A) locus: identification of novel HTR2A and antisense (HTR2A-AS1) exons.A reliable method for quantification of splice variants using RT-qPCR.Regulation and Functional Implications of Opioid Receptor Splicing in Opioid Pharmacology and HIV PathogenesisHypertension pharmacogenomics: in search of personalized treatment approachesTranscriptomic variation of pharmacogenes in multiple human tissues and lymphoblastoid cell linesMechano-regulation of alternative splicing.Recent genetic findings in schizophrenia and their therapeutic relevanceGene isoforms as expression-based biomarkers predictive of drug response in vitro.Expression of ZNF804A in human brain and alterations in schizophrenia, bipolar disorder, and major depressive disorder: a novel transcript fetally regulated by the psychosis risk variant rs1344706.Advancing psychiatric pharmacogenomics using drug development paradigms.Whole Transcriptome Profiling: An RNA-Seq Primer and Implications for Pharmacogenomics Research.Hiding in the Shadows: CPOX Expression and 5-ALA Induced Fluorescence in Human Glioma Cells.
P2860
Q26852848-135B5DF9-5452-48E4-ABB3-B25831D35EBCQ26860519-92DB46AA-0E5D-44CF-B0CA-0D3BB8CAA5C2Q26866357-96F06C37-B0C6-480E-BE30-72F528A97EBEQ28535228-576807ED-9C0B-48F8-AED5-FE01AFFDB4F7Q30962063-B15B4625-1D26-43FA-8718-9F4ED513217DQ33737782-F3143C6B-5A55-4C0F-9E58-AAB0034DDF10Q34152280-54F24789-44B4-499B-BAD0-9ACD92B6B414Q35037624-25F63019-DFD5-4E24-8737-814A60785063Q35887385-406BE4D1-21CC-4139-956A-C6C4DEC970F9Q35958211-94AE3877-64CD-4868-855F-F07DDDD662AEQ36505623-310ADEFD-C45C-4E8E-BFA2-2EFDA2730BCBQ36652960-07920850-B8EA-4B61-85ED-56192A6BD593Q37165815-4BF4B5FF-A473-456B-B717-3827E0A5BABAQ38133542-120FE718-A4DA-43F4-87A7-951AD5C8F714Q38260258-81BE58A9-27C2-46C6-BAFC-CAB534CB42C8Q42635307-A9ECFD6A-8566-49F2-BBFE-B392FD5908EAQ48224902-0634302C-6B08-485A-8B43-B901F4AB8F30Q49627711-BA087EF4-CA6F-4E55-97F1-49FE5D8E60A7Q49841634-7F9FAE4A-6910-413F-BB53-64ED1418DD8CQ51490310-AFBB0DEE-7C7A-40C7-962E-D8C2FFF673E4
P2860
mRNA transcript diversity creates new opportunities for pharmacological intervention.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
mRNA transcript diversity creates new opportunities for pharmacological intervention.
@ast
mRNA transcript diversity creates new opportunities for pharmacological intervention.
@en
type
label
mRNA transcript diversity creates new opportunities for pharmacological intervention.
@ast
mRNA transcript diversity creates new opportunities for pharmacological intervention.
@en
prefLabel
mRNA transcript diversity creates new opportunities for pharmacological intervention.
@ast
mRNA transcript diversity creates new opportunities for pharmacological intervention.
@en
P2093
P2860
P356
P1476
mRNA transcript diversity creates new opportunities for pharmacological intervention.
@en
P2093
Elizabeth S Barrie
Jonathan C Sanford
Ryan M Smith
P2860
P304
P356
10.1124/MOL.111.076604
P577
2012-02-07T00:00:00Z